Organ Transplant Insurance Denied: How to Appeal

Organ transplantation — including kidney, liver, heart, lung, pancreas, and small intestine transplants — is the only curative option for end-stage organ failure. Insurance coverage disputes around transplantation are high-stakes and emotionally devastating. They can arise at any stage: evaluation for transplant listing, the transplant procedure itself, post-transplant immunosuppression, or organ procurement. This guide covers each scenario and how to build an effective appeal.

Transplant Coverage Denial Scenarios

Transplant Listing: "Too Sick" or "Not Sick Enough"

Organ allocation is governed by the United Network for Organ Sharing (UNOS) and its organ procurement and transplantation network (OPTN). Patients must meet transplant center listing criteria and UNOS eligibility requirements. Insurance disputes often arise when:

• "Too sick": The insurer argues the patient won't survive surgery or won't benefit. This is a clinical determination that must be challenged with specialist opinion. A different transplant center may reach a different listing decision.

• "Not sick enough": For some organs, particularly liver (MELD score–based allocation) or lung (LAS score–based allocation), insurers may argue that the severity threshold for transplant isn't met. Document current organ function with objective measures: creatinine/GFR for kidney, MELD score for liver, FVC/FEV1 and LAS for lung, EF and hemodynamic parameters for heart.

Center-of-Excellence Requirements

Many commercial plans require transplants to be performed at a "center of excellence" — typically a high-volume transplant center with specific quality metrics. Disputes arise when:

• The designated center is geographically inaccessible
• The patient's transplant team is not at a designated center
• The patient has an established relationship with a non-designated but highly qualified center

Appeal argument: Request a list of all designated centers in your plan, assess the nearest designated center, and if it's unreasonably far, argue that network adequacy laws require the plan to provide access at a reasonable distance. If geographic access is a barrier, request a single-case agreement allowing the established center to provide care at in-network rates.

Post-Transplant Immunosuppressants

Lifelong immunosuppression is not optional after transplant — rejection leads to graft loss and death. Denied immunosuppressants include:

• Tacrolimus (Prograf, generic)
• Cyclosporine (Neoral, generic)
• Mycophenolate mofetil (CellCept, generic)
• Azathioprine
• Prednisone
• Sirolimus (Rapamune)
• Belatacept (Nulojix)

Medicare coverage: Effective January 1, 2023, Medicare covers post-transplant immunosuppressants for the lifetime of the transplant, with no 36-month limit. If denied by Medicare citing the former limit, cite the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (and its extension to all organ transplants).

Generic vs. brand disputes: Tacrolimus is a narrow therapeutic index (NTI) drug — small changes in blood levels can cause rejection or toxicity. If your transplant team has documented that a specific brand or formulation is clinically necessary, and the insurer requires a generic substitution, argue that NTI drug substitution requires transplant team approval and cite FDA NTI drug guidance.

Organ Procurement Costs

Organ procurement — recovery and transport of the donor organ — is typically covered as part of the transplant benefit. Some plans dispute specific procurement costs. These should be challenged as part of the standard transplant surgical episode.

Living Donor Evaluation and Surgery

For living-donor kidney or liver transplants, the donor's medical evaluation and surgical care should be covered by the recipient's health plan under federal NOTA (National Organ Transplant Act) provisions and most state laws. If a plan is denying living donor workup or surgical costs, this is often improper — and the American Society of Transplantation and UNOS strongly advocate for living donor coverage. Cite NOTA and request explicit coverage as part of the transplant benefit.

Building Your Transplant Appeal

Transplant Team Documentation

Your transplant center's team — transplant hepatologist, nephrologist, cardiac surgeon, transplant coordinator — should provide detailed letters of medical necessity addressing:

• Diagnosis and stage of organ failure (objective measures: MELD, LAS, EF, GFR)
• Why transplant is the appropriate treatment
• Expected outcomes with and without transplant
• Urgency of listing

UNOS and OPTN Criteria

UNOS allocation policies and OPTN minimum listing criteria are the medical standards for transplant listing. If your payer's criteria conflict with UNOS standards, note this discrepancy — payer criteria cannot ethically or legally impose lower eligibility standards than the national transplant system's evidence-based requirements.

Cite Transplantation Society Guidelines

The American Society of Transplantation (AST), American Society of Transplant Surgeons (ASTS), and organ-specific professional societies publish evidence-based guidelines for transplant candidacy, immunosuppression protocols, and post-transplant care. Include relevant guideline citations in your appeal.

COBRA and Continuity of Coverage

Transplant patients who lose employment during their transplant workup or recovery may need to maintain coverage through COBRA to preserve transplant and immunosuppressant coverage. This is a significant concern — plan proactively with a case manager or social worker at your transplant center.

External Independent Review: Complete Guide" class="auto-link">External Review

Transplant denials are among the most clinically complex — and external independent reviewers with transplant specialty expertise can overturn denials that internal reviewers lack the expertise to evaluate correctly.

Resources

• UNOS (unos.org) — transplant listing standards, patient advocacy resources
• American Society of Transplantation (AST) (myast.org) — patient education and advocacy
• Transplant center social workers and financial coordinators — most centers have staff dedicated to insurance navigation; use them
• National Foundation for Transplants (NFT) — fundraising and financial assistance for transplant patients
• NORD and disease-specific organizations — for transplants related to rare genetic diseases

A transplant denial is never the final word — with organized documentation, transplant center support, and if needed, external review, these cases can be resolved.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word. Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• What Is Step Therapy?